Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Efficacy and Safety of Growth Hormone Treatment in Juvenile Idiopathic Arthritis

This study has been completed.
Sponsor:
Collaborator:
Pfizer
Information provided by:
Ludwig-Maximilians - University of Munich
ClinicalTrials.gov Identifier:
NCT00420251
First received: January 9, 2007
Last updated: NA
Last verified: January 2007
History: No changes posted